Case Study: Cue Biopharma achieves accelerated, traceable biologics process development with Benchling

Improving data management for modern Biologics process development

Cue Biopharma is a clinical-stage biotech in Cambridge developing a novel class of injectable biologics to engage disease-relevant T cells for cancer and autoimmune disease. As the company scaled its in‑house process development, it struggled to track experimental context and sample history across the product lifecycle, bridge handoffs between research and development teams, and accommodate evolving workflows within rigid legacy data systems.

Cue implemented Benchling as a unified data platform to capture sample names, locations, histories and results, coordinate samples and automated handoffs across teams, and support flexible data structures that absorb new modalities. The system streamlined management of >4,000 engineered constructs, shortened process development cycles, improved cross‑functional collaboration and onboarding, and made data easier to share with partners—accelerating candidate advancement and enabling more efficient, innovative R&D.

Cue Biopharma

Samantha Povlich

Director of Analytical Operations and CMC Digital Strategy Biopharma